$MANH
Manhattan Associates Inc

2012 Q3 Form 10-Q Financial Statement

#000119312512443618 Filed on October 31, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2011 Q3
Revenue $95.84M $85.60M
YoY Change 11.96% 15.68%
Cost Of Revenue $41.13M $35.95M
YoY Change 14.42% 8.27%
Gross Profit $54.71M $49.66M
YoY Change 10.18% 21.71%
Gross Profit Margin 57.09% 58.01%
Selling, General & Admin $20.26M $20.21M
YoY Change 0.25% 5.8%
% of Gross Profit 37.02% 40.69%
Research & Development $11.40M $10.88M
YoY Change 4.81% 9.87%
% of Gross Profit 20.84% 21.9%
Depreciation & Amortization $1.379M $1.698M
YoY Change -18.79% -26.17%
% of Gross Profit 2.52% 3.42%
Operating Expenses $31.66M $31.08M
YoY Change 1.84% -0.37%
Operating Profit $21.68M $19.39M
YoY Change 11.77% 102.02%
Interest Expense -$300.0K $900.0K
YoY Change -133.33% -550.0%
% of Operating Profit -1.38% 4.64%
Other Income/Expense, Net -$247.0K $862.0K
YoY Change -128.65%
Pretax Income $21.43M $20.26M
YoY Change 5.8% 115.49%
Income Tax $7.621M $5.379M
% Of Pretax Income 35.56% 26.56%
Net Earnings $13.81M $14.88M
YoY Change -7.18% 139.95%
Net Earnings / Revenue 14.41% 17.38%
Basic Earnings Per Share $0.18 $0.74
Diluted Earnings Per Share $0.17 $0.70
COMMON SHARES
Basic Shares Outstanding 78.27M shares 20.16M shares
Diluted Shares Outstanding 80.52M shares 21.13M shares

Balance Sheet

Concept 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.8M $100.8M
YoY Change 5.95% -11.73%
Cash & Equivalents $99.09M $94.15M
Short-Term Investments $7.700M $6.700M
Other Short-Term Assets $15.30M $16.00M
YoY Change -4.38% 35.59%
Inventory
Prepaid Expenses
Receivables $73.24M $56.70M
Other Receivables $0.00 $0.00
Total Short-Term Assets $195.3M $173.5M
YoY Change 12.59% -0.74%
LONG-TERM ASSETS
Property, Plant & Equipment $13.68M $13.50M
YoY Change 1.34% -10.0%
Goodwill $62.26M
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $900.0K
YoY Change -100.0% -62.5%
Other Assets $4.500M $12.60M
YoY Change -64.29% -5.97%
Total Long-Term Assets $80.48M $89.20M
YoY Change -9.77% -5.81%
TOTAL ASSETS
Total Short-Term Assets $195.3M $173.5M
Total Long-Term Assets $80.48M $89.20M
Total Assets $275.8M $262.7M
YoY Change 5.0% -2.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.069M $8.300M
YoY Change -2.78% 13.7%
Accrued Expenses $29.60M $30.20M
YoY Change -1.99% -11.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $97.30M $92.50M
YoY Change 5.19% 12.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.000M $9.000M
YoY Change 0.0% -13.46%
Total Long-Term Liabilities $9.000M $9.000M
YoY Change 0.0% -13.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $97.30M $92.50M
Total Long-Term Liabilities $9.000M $9.000M
Total Liabilities $106.3M $101.4M
YoY Change 4.83% 9.39%
SHAREHOLDERS EQUITY
Retained Earnings $173.2M
YoY Change
Common Stock $199.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $169.6M $161.3M
YoY Change
Total Liabilities & Shareholders Equity $275.8M $262.7M
YoY Change 5.0% -2.52%

Cashflow Statement

Concept 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income $13.81M $14.88M
YoY Change -7.18% 139.95%
Depreciation, Depletion And Amortization $1.379M $1.698M
YoY Change -18.79% -26.17%
Cash From Operating Activities $17.40M $16.90M
YoY Change 2.96% 46.96%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M -$1.700M
YoY Change -41.18% 6.25%
Acquisitions
YoY Change
Other Investing Activities -$1.400M $1.200M
YoY Change -216.67% -114.12%
Cash From Investing Activities -$2.600M -$500.0K
YoY Change 420.0% -95.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.00M -24.60M
YoY Change -51.22% 68.49%
NET CHANGE
Cash From Operating Activities 17.40M 16.90M
Cash From Investing Activities -2.600M -500.0K
Cash From Financing Activities -12.00M -24.60M
Net Change In Cash 2.800M -8.200M
YoY Change -134.15% -38.35%
FREE CASH FLOW
Cash From Operating Activities $17.40M $16.90M
Capital Expenditures -$1.000M -$1.700M
Free Cash Flow $18.40M $18.60M
YoY Change -1.08% 41.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q1 manh Tax Credit Carryforward Reduction In Valuation Allowance
TaxCreditCarryforwardReductionInValuationAllowance
2000000
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94153000
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7465000
CY2012Q3 us-gaap Goodwill
Goodwill
62260000
CY2012Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
7835000
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
CY2012Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
169560000
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7066000
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16857000
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19905903 shares
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8069000
CY2012Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
1874000
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
52573000
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2012Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2668000
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
173248000
CY2012Q3 us-gaap Assets
Assets
275829000
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
73241000
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
275829000
CY2012Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
36700000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99090000
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19905903 shares
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3887000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
611616 shares
CY2012Q3 us-gaap Cash
Cash
62400000
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
97298000
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5524000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
619649 shares
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
7715000
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
199000
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Assets Current
AssetsCurrent
195346000
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13681000
CY2012Q3 manh Other Noncurrent Liability
OtherNoncurrentLiability
8971000
CY2012Q3 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
12733000
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19870636 shares
CY2008Q4 us-gaap Availableforsale Securities Failed Auction Value
AvailableforsaleSecuritiesFailedAuctionValue
0
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120744000
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7533000
CY2011Q4 us-gaap Goodwill
Goodwill
62261000
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
7599000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3325000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
95569000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.259 pure
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30265000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40995000
CY2011Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
162080000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16503000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20415946 shares
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8090000
CY2011Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
2953000
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
49882000
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2011Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4859000
CY2011Q4 us-gaap Long Term Investments
LongTermInvestments
855000
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5696000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
166989000
CY2011Q4 us-gaap Assets
Assets
259600000
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
56264000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
259600000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92180000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20415946 shares
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5113000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
655155 shares
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
88123000
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4816000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1633566 shares
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
6079000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
204000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Assets Current
AssetsCurrent
174514000
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13321000
CY2011Q4 manh Other Noncurrent Liability
OtherNoncurrentLiability
9397000
CY2011Q4 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
13648000
us-gaap Costs And Expenses
CostsAndExpenses
200554000
us-gaap Operating Income Loss
OperatingIncomeLoss
45160000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1214000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32141000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
356232 shares
us-gaap Maintenance Revenue
MaintenanceRevenue
64709000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5922000
us-gaap Share Based Compensation
ShareBasedCompensation
7317000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.59
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3207000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4267000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
118737000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1500000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3672000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26591000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27256000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1546000
us-gaap Restricted Stock Expense
RestrictedStockExpense
5800000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21656000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
245714000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9370000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
46374000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33774000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2241000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.67
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2241000
us-gaap Licenses Revenue
LicensesRevenue
37674000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31936000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63888000
us-gaap Cost Of Revenue
CostOfRevenue
104185000
us-gaap Operating Expenses
OperatingExpenses
92966000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1416000
us-gaap Cost Of Services
CostOfServices
80474000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
513000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20623000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1033000 shares
us-gaap License Costs
LicenseCosts
4259000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-465000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
183446000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-22000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1821000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17000 shares
us-gaap Reimbursement Revenue
ReimbursementRevenue
8000000
us-gaap Net Income Loss
NetIncomeLoss
34382000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1416000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11992000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-491000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6250000
manh Effect Of Common Equivalent Shares On Earning Per Share
EffectOfCommonEquivalentSharesOnEarningPerShare
-0.08
manh Tax Benefit Deficiency Of Stock Awards Exercised Vested
TaxBenefitDeficiencyOfStockAwardsExercisedVested
3345000
manh Royalty Fees Americas Charge To Other Segment Based On Software License Sold By Those Segments
RoyaltyFeesAmericasChargeToOtherSegmentBasedOnSoftwareLicenseSoldByThoseSegments
1700000
manh Hardware Revenue And Other
HardwareRevenueAndOther
24594000
manh Cost Of Hardware And Other
CostOfHardwareAndOther
19452000
manh Recovery Of Previously Impaired Investment
RecoveryOfPreviouslyImpairedInvestment
2519000
dei Trading Symbol
TradingSymbol
MANH
dei Entity Registrant Name
EntityRegistrantName
MANHATTAN ASSOCIATES INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001056696
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Costs And Expenses
CostsAndExpenses
219930000
us-gaap Operating Income Loss
OperatingIncomeLoss
60959000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
53000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
431000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40609000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
226905 shares
us-gaap Maintenance Revenue
MaintenanceRevenue
72378000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4141000
us-gaap Share Based Compensation
ShareBasedCompensation
5795000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.93
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1595000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1005508 shares
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
71667000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.358 pure
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25708000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51407000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4572000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2494000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
240852 shares
us-gaap Technology Services Revenue
TechnologyServicesRevenue
139200000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
400000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4336000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6910000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28806000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1215000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>9. New Accounting Pronouncements</b></font></p> <p style="margin-top:6px;margin-bottom:0px; text-indent:8%"> <font style="font-family:Times New Roman" size="2">In September 2011, the FASB issued an Accounting Standards Update on testing goodwill for impairment to simplify the goodwill impairment test. The standard update is intended to reduce cost and complexity of the annual goodwill impairment test by permitting companies to first assess qualitative factors to determine whether further impairment testing is necessary. Under this standard update, a company is not required to calculate the fair value of a reporting unit unless the company determines that it is more likely than not that its fair value is less than its carrying amount. The more likely than not threshold is defined as having a likelihood of more than 50 percent. This guidance is effective for interim and annual goodwill impairment tests performed for the fiscal years beginning after December&#xA0;15, 2011. The Company does not expect the adoption of this guidance to have a material impact on its financial statements.</font></p> <p style="margin-top:12px;margin-bottom:0px; text-indent:8%"> <font style="font-family:Times New Roman" size="2">In May 2011, the FASB issued an Accounting Standards Update on fair value measurements that clarifies the application of existing guidance and disclosure requirements, changes certain fair value measurement principles and requires additional disclosures about fair value measurements. This guidance is effective for interim and annual periods beginning after December&#xA0;15, 2011. The Company adopted the enhanced disclosures for Level 3 in its first quarter of 2012 reporting, which did not have a material impact on its financial statements.</font></p> </div>
us-gaap Restricted Stock Expense
RestrictedStockExpense
5400000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20372000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
280889000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16772000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
61390000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34817000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1226000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1134000
us-gaap Licenses Revenue
LicensesRevenue
47096000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33753000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40233000
us-gaap Cost Of Revenue
CostOfRevenue
118413000
us-gaap Operating Expenses
OperatingExpenses
97376000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5726000
us-gaap Cost Of Services
CostOfServices
94646000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-411000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19745000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
627000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
8409 shares
us-gaap License Costs
LicenseCosts
5351000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
236000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
211578000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
46000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2807000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Reimbursement Revenue
ReimbursementRevenue
9200000
us-gaap Net Income Loss
NetIncomeLoss
39383000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5726000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22007000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
308000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
92000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
29592 shares
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
12266000
manh Effect Of Common Equivalent Shares On Earning Per Share
EffectOfCommonEquivalentSharesOnEarningPerShare
-0.06
manh Tax Benefit Deficiency Of Stock Awards Exercised Vested
TaxBenefitDeficiencyOfStockAwardsExercisedVested
7034000
manh Royalty Fees Americas Charge To Other Segment Based On Software License Sold By Those Segments
RoyaltyFeesAmericasChargeToOtherSegmentBasedOnSoftwareLicenseSoldByThoseSegments
2300000
manh Hardware Revenue And Other
HardwareRevenueAndOther
22215000
manh Cost Of Hardware And Other
CostOfHardwareAndOther
18416000
CY2008 us-gaap Impairment Of Investments
ImpairmentOfInvestments
3500000
CY2012Q2 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
1000000
CY2011Q3 us-gaap Costs And Expenses
CostsAndExpenses
66208000
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
19394000
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
862000
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12459000
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
19840 shares
CY2011Q3 us-gaap Maintenance Revenue
MaintenanceRevenue
22191000
CY2011Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1698000
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2011Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266 pure
CY2011Q3 us-gaap Technology Services Revenue
TechnologyServicesRevenue
41403000
CY2011Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
500000
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9342000
CY2011Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
2000000
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21125000 shares
CY2011Q3 us-gaap Sales Revenue Net
SalesRevenueNet
85602000
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
20256000
CY2011Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10865000
CY2011Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2418000
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2011Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2418000
CY2011Q3 us-gaap Licenses Revenue
LicensesRevenue
13565000
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10877000
CY2011Q3 us-gaap Cost Of Revenue
CostOfRevenue
35945000
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
31084000
CY2011Q3 us-gaap Cost Of Services
CostOfServices
28054000
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20156000 shares
CY2011Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
969000 shares
CY2011Q3 us-gaap License Costs
LicenseCosts
1196000
CY2011Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
63594000
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000 shares
CY2011Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
2900000
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
14877000
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5379000
CY2011Q3 manh Recovery Rate Of Previously Impaired Investment
RecoveryRateOfPreviouslyImpairedInvestment
0.72 pure
CY2011Q3 manh Effect Of Common Equivalent Shares On Earning Per Share
EffectOfCommonEquivalentSharesOnEarningPerShare
-0.04
CY2011Q3 manh Royalty Fees Americas Charge To Other Segment Based On Software License Sold By Those Segments
RoyaltyFeesAmericasChargeToOtherSegmentBasedOnSoftwareLicenseSoldByThoseSegments
500000
CY2011Q3 manh Hardware Revenue And Other
HardwareRevenueAndOther
8443000
CY2011Q3 manh Cost Of Hardware And Other
CostOfHardwareAndOther
6695000
CY2011Q3 manh Recovery Of Previously Impaired Investment
RecoveryOfPreviouslyImpairedInvestment
2519000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
74164000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
21677000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-247000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15677000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
10830 shares
CY2012Q3 us-gaap Maintenance Revenue
MaintenanceRevenue
24804000
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1379000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2012Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.356 pure
CY2012Q3 us-gaap Technology Services Revenue
TechnologyServicesRevenue
47082000
CY2012Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9258000
CY2012Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
2000000
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20130000 shares
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
95841000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21430000
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10999000
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1868000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2012Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1868000
CY2012Q3 us-gaap Licenses Revenue
LicensesRevenue
16164000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11400000
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
41128000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
31657000
CY2012Q3 us-gaap Cost Of Services
CostOfServices
32614000
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19568000 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
562000 shares
CY2012Q3 us-gaap License Costs
LicenseCosts
2086000
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
71886000
CY2012Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
3600000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
13809000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7621000
CY2012Q3 manh Effect Of Common Equivalent Shares On Earning Per Share
EffectOfCommonEquivalentSharesOnEarningPerShare
-0.02
CY2012Q3 manh Royalty Fees Americas Charge To Other Segment Based On Software License Sold By Those Segments
RoyaltyFeesAmericasChargeToOtherSegmentBasedOnSoftwareLicenseSoldByThoseSegments
400000
CY2012Q3 manh Hardware Revenue And Other
HardwareRevenueAndOther
7791000
CY2012Q3 manh Cost Of Hardware And Other
CostOfHardwareAndOther
6428000

Files In Submission

Name View Source Status
0001193125-12-443618-index-headers.html Edgar Link pending
0001193125-12-443618-index.html Edgar Link pending
0001193125-12-443618.txt Edgar Link pending
0001193125-12-443618-xbrl.zip Edgar Link pending
d413803d10q.htm Edgar Link pending
d413803dex311.htm Edgar Link pending
d413803dex312.htm Edgar Link pending
d413803dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
manh-20120930.xml Edgar Link completed
manh-20120930.xsd Edgar Link pending
manh-20120930_cal.xml Edgar Link unprocessable
manh-20120930_def.xml Edgar Link unprocessable
manh-20120930_lab.xml Edgar Link unprocessable
manh-20120930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending